PortfoliosLab logoPortfoliosLab logo
ELIS vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

ELIS vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily LLY Bear 1X Shares (ELIS) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


ELIS

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

IHE

1D
1.16%
1M
1.80%
YTD
6.47%
6M
8.51%
1Y
40.15%
3Y*
17.47%
5Y*
9.98%
10Y*
7.81%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELIS vs. IHE - Yearly Performance Comparison


2026 (YTD)2025
ELIS
Direxion Daily LLY Bear 1X Shares
11.37%-29.46%
IHE
iShares U.S. Pharmaceuticals ETF
6.47%25.34%

Correlation

The correlation between ELIS and IHE is -0.71, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.71

Correlation (All Time)
Calculated using the full available price history since Mar 27, 2025

-0.75

The correlation between ELIS and IHE has been stable across timeframes, ranging from -0.75 to -0.71 - a consistent structural relationship.

ELIS vs. IHE - Sectors Allocation Comparison


Sectors
ELIS
IHE

Financial Services

100.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Healthcare

-

100.0%

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Financial Services

ELIS
100.0%
IHE

-

Basic Materials

ELIS

-

IHE

-

Communication Services

ELIS

-

IHE

-

Consumer Cyclical

ELIS

-

IHE

-

Consumer Defensive

ELIS

-

IHE

-

Energy

ELIS

-

IHE

-

Healthcare

ELIS

-

IHE
100.0%

Industrials

ELIS

-

IHE

-

Real Estate

ELIS

-

IHE

-

Technology

ELIS

-

IHE

-

Utilities

ELIS

-

IHE

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELIS vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELIS

IHE
IHE Risk / Return Rank: 7474
Overall Rank
IHE Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 7575
Sortino Ratio Rank
IHE Omega Ratio Rank: 6565
Omega Ratio Rank
IHE Calmar Ratio Rank: 8585
Calmar Ratio Rank
IHE Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELIS vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily LLY Bear 1X Shares (ELIS) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

ELIS vs. IHE - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


ELISIHEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.36

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.62

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.43

Sharpe Ratio (All Time)

Calculated using the full available price history

0.51

Drawdowns

ELIS vs. IHE - Drawdown Comparison


Loading charts...

Drawdown Indicators


ELISIHEDifference

Max Drawdown

Largest peak-to-trough decline

-38.20%

Max Drawdown (1Y)

Largest decline over 1 year

-8.47%

Max Drawdown (3Y)

Largest decline over 3 years

-15.92%

Max Drawdown (5Y)

Largest decline over 5 years

-16.03%

Max Drawdown (10Y)

Largest decline over 10 years

-29.59%

Current Drawdown

Current decline from peak

-2.80%

Average Drawdown

Average peak-to-trough decline

-7.92%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.81%

Volatility

ELIS vs. IHE - Volatility Comparison


Loading charts...

Volatility by Period


ELISIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.53%

Volatility (6M)

Calculated over the trailing 6-month period

12.48%

Volatility (1Y)

Calculated over the trailing 1-year period

17.07%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.05%

ELIS vs. IHE - Expense Ratio Comparison

ELIS has a 0.97% expense ratio, which is higher than IHE's 0.42% expense ratio.


Dividends

ELIS vs. IHE - Dividend Comparison

ELIS's dividend yield for the trailing twelve months is around 5.26%, more than IHE's 1.65% yield.


PositionTTM20252024202320222021202020192018201720162015
ELIS
Direxion Daily LLY Bear 1X Shares
5.26%5.86%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IHE
iShares U.S. Pharmaceuticals ETF
1.65%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%

Frequently Asked Questions


ELIS and IHE have a correlation of -0.71, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, IHE is cheaper at 0.42% per year. The better choice depends on whether you care most about return, fees, risk, or income.

IHE is cheaper with a 0.42% expense ratio, compared with 0.97% for ELIS.

ELIS has the higher dividend yield at 5.26%, compared with 1.65% for IHE.

ELIS is categorized as Inverse Equities, while IHE is Health & Biotech Equities. They also come from different issuers: Direxion and iShares. Their fees differ too: 0.97% for ELIS and 0.42% for IHE.

Portfolio Optimizer

Find the right allocation for ELIS and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer